| Returns | 1W : -1.8% , 1M : 0.7%,1Y : 31.9% |
| ST : |
Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward Pledged Shares : None or < 25% |
| Peers & Returns | 1W | 1M | 1Y |
| DR REDDYS LABORATORIES | -1.8% | 0.7% | 31.9% |
| SUN PHARMACEUTICAL INDUSTRIES | -0.4% | -3.5% | 37.6% |
| DIVIS LABORATORIES | -0.3% | 4.7% | 83.8% |
| CIPLA | -0.1% | 2.7% | 50.7% |
| BIOCON | -0.5% | 4.7% | 6.3% |
| AUROBINDO PHARMA | -3.6% | -6.1% | 21.9% |
| LUPIN | -1.4% | -3.1% | 26.6% |
| TORRENT PHARMACEUTICALS | 1.3% | 7.7% | 14.8% |
| CADILA HEALTHCARE | -0% | 1.4% | 73.9% |
| Ratio | Consolidated |
|---|---|
|
P/E P/B P/S |
43.54
P/E Calculated based on EPS of 121.9
[ Mar2020 - Consolidated Results ] 5.69
P/B Calculated based on Book Value of 932.31
[ Mar2020 - Consolidated Results ] 4.71
P/S Calculated based on Revenues of 18728.2 Cr
[ TTM - Consolidated Results ] |
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
137% 51% 56% |
| Pledged Shares |
0 % |
|---|---|
| As on : Mar2021 | |
If less than 25% | Good |
| If between 25% and 50% | Neutral |
| If greater than 50% | Bad |
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE 500 SHARIAH | 0.4% | 6.6% | 66.1% |
| S&P BSE SENSEX | 0.2% | 3.8% | 51.4% |
| S&P BSE 100 LARGECAP TMC | 0% | 3.8% | 54.7% |
| S&P BSE SENSEX50 | -0% | 3.8% | 54.2% |
| S&P BSE LOW VOLATILITY | -0% | 5.9% | 52.6% |
| S&P BSE LARGECAP | -0% | 3.8% | 54.1% |
| S&P BSE MOMENTUM | -0.1% | 5.1% | 40.4% |
| S&P BSE 100 | -0.1% | 3.8% | 54.9% |
| S&P BSE ALLCAP | -0.1% | 4.3% | 62.2% |
| S&P BSE CARBONEX | -0.1% | 3.6% | 55.6% |
| S&P BSE 100 ESG INDEX | -0.1% | 4.4% | 59.8% |
| S&P BSE 500 | -0.1% | 4.1% | 60.8% |
| S&P BSE LARGE MIDCAP | -0.2% | 3.8% | 56.8% |
| S&P BSE 250 LARGEMIDCAP | -0.2% | 4% | 58.4% |
| S&P BSE 200 | -0.2% | 3.9% | 58% |
| S&P BSE GREENEX | -0.3% | 3% | 58.3% |
| MFG | -0.4% | 3.6% | 45.9% |
| S&P BSE HEALTHCARE | -0.8% | 1.4% | 53.6% |
| S&P BSE DIVIDEND STABILITY | -1.1% | 2.9% | 55% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY 50 | 0% | 3.8% | 53.7% |
| NIFTY 100 | 0% | 3.8% | 53.7% |
| NIFTY 500 | -0.1% | 4.1% | 60.1% |
| NIFTY 200 | -0.2% | 3.9% | 56.9% |
| NIFTY 100 EQUAL WEIGHT | -0.3% | 3.9% | 61.8% |
| NIFTY ALPHA QTY LOW-VOLAT.30 | -0.8% | 4.2% | 47.2% |
| NIFTY ALPHA LOW-VOLATILTY 30 | -0.8% | 4.8% | 45.5% |
| NIFTY PHARMA | -0.9% | 0.4% | 40.8% |
| NIFTY ALPHA QTY VAL LOW-VOL 30 | -1% | 4.8% | 46.5% |
| NIFTY GROWTH SECTOR 15 | -1.1% | 1.1% | 48.6% |
| NIFTY500 MULTICAP 50:25:25 | -1.3% | 4.8% | NA |
| NIFTY LARGE MIDCAP 250 | -1.6% | 4.6% | 68.4% |
#15A, 4th Floor, City Vista, Tower A,
Suite No.984, Fountain Road,
Kharadi, Pune - 411014
Contact Us
support@smart-investing.in
Smart-Investing.in
Pricing
Video Course
Blog
Tools
Screener
Compare
Analyze Portfolio
© 2019 - 2021 Smart-Investing.in. All rights reserved. Built with ❤️ in India
Disclaimer
The information on this site is for educational purposes only and is not investment/trading advice/research and may be delayed.
We don't make any Buy/Sell recommendations and don't give any price targets.
This tool provides statistical summaries of financial data in easy to understand visual form for informational purpose only.
Please do your own research before making any investment decisions.
Equity investments are volatile and high risk in nature. Don't invest more than what you can afford to lose.
Financial Data Source: Accord Fintech |
Methodology |
Privacy Policy |
Terms & Conditions |
